Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations.
Cancers (Basel)
2023
15
3
[ECMO support during the first two waves of the corona pandemic-a survey of high case volume centers in Germany].
Med Klin Intensivmed Notfmed
2023
118
6
492-498